Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	157.84M
Revenue (ttm)	89.88M
Net Income (ttm)	16.93M
Shares Out	581.33M
EPS (ttm)	0.03
PE Ratio	10.08
Forward PE	7.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	139,506
Average Volume	736,142
Open	0.3620
Previous Close	0.3600
Day's Range	0.3500 - 0.3680
52-Week Range	0.2750 - 0.5400
Beta	0.26
RSI	54.73
Earnings Date	May 30, 2025

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,309
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2024, LON:IDHC's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP